Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis

British Journal of Ophthalmology

Volumn 86, Issue 10, 2002, Pages 1175-1180

  Abu El Asrar, Ahmed M ^a   Struyf, S ^b   Al Kharashi, S A ^a   Missotten, L ^c   Van Damme, J ^b   Geboes, K ^d  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; CD71 ANTIGEN; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE I 309; CHEMOKINE RECEPTOR CCR4; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 2 RECEPTOR; L SELECTIN; MACROPHAGE DERIVED CHEMOKINE; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC REACTION; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LYMPHOCYTE ACTIVATION; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; T LYMPHOCYTE; VERNAL CONJUNCTIVITIS;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTIGENS, CD; ANTIGENS, CD3; BIOLOGICAL MARKERS; CHEMOKINES; CHEMOKINES, CC; CHEMOTACTIC FACTORS; CHILD; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES;

EID: 0036785377     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.10.1175     Document Type: Article

References (60)

1. Abu El-Asrar AM, Geboes K, Al-Kharashi S, et al. Adhesion molecules in vernal keratoconjunctivitis. Br J Ophthalmol 1997;81:1099-106.
2. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-46.
3. + cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1-6.
4. Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999;29:1214-22.
5. Metz DP Hingorani M, Calder VL, et al. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997;100:817-24.
6. Leonardi A, De Franchis G, Zancanaro F, et al. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci 1999;40:3036-40.
7. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
8. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-42.
9. Murphy PM, Baggiolini M, Charo IF, et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000;52:145-76.
10. Abu El-Asrar AM, Struyf S, Al-Kharashi SA, et al. Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol 2000;84:1360-6.
11. Abu El-Asrar AM, Struyf S, Al Mosallam AA, et al. Expression of chemokine receptors in vernal keratoconjunctivitis. Br J Ophthalmol 2001;85:1357-61.
12. Adema GJ, Hartgers F, Verstraten R, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997;387:713-17.
13. Imai T, Chantry D, Rapart CJ, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998;273;1764-6.
14. Zingoni A Soto H, Hedrick JA, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161:547-51.
15. Reape TJ, Rayner K, Manning CD, et al. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol 1999;154:365-74.
16. Hieshima K, Imai T, Baba M, et al. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1α/LD78α and chemotactic for T lymphocytes, but not for monocytes. J Immunol 1997;159:1140-9.
17. Sallusto F, Palermo B, Lenig D et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999;29:1617-25.
18. Vissers JLM, Hartgers FC, Lindhout E, et al. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukoc Biol 2001;69:785-93.
19. Koclelja V, Müller C, Politz O, et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1α with a Th2-associated expression pattern. J Immunol 1998;160:1411-18.
20. Chang M, McNinch J, Elias C III, et al. Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J Biol Chem 1997;272:25229-37.
21. Godiska R, Chantry D, Raport CJ, et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 1997;185:1595-604.
22. Schaniel C, Pardali E, Sallusto F et al. Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med 1998;188:451-63.
23. Mantovani A, Gray PA, Van Damme J, et al. Macrophage-derived chemokine. J Leukoc Biol 2000;68:400-4.
24. Andrew DP, Chang MS, McNinch J, et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998;161:5027-38.
25. Vulcano M, Albanesi C, Stoppacciara A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo. Eur J Immunol 2001;31:812-22.
26. Galli G, Chantry D, Annunzioto F, et al. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur J Immunol 2000;30:204-10.
27. D'Ambrosio D, Iellem A, Bonecchi R, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:5111-15.
28. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokine thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999;11:81-8.
29. Bochner BS, Bickel CA, Taylor ML, et al. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3-and CC chemokine receptor 4-independent manner. J Allergy Clin Immunol 1999;103:527-32.
30. Gonzalo JA, Pan Y, Lloyd CM, et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 1999;163: 400-11.
31. Lloyd CM, Delaney T, Nguyen T, et al. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000;191:265-73.
32. Selvan RS, Zhou LJ, Krangel MS. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol 1997;27:687-94.
33. Innglerdinger M, Damaj B, Maghazachi AA. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 2000;164: 4048-54.
34. de Lavareille A, Roufosse F, Schandene L, et al. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo. Eur J Immunol 2001;31:1037-46.
35. Bonecchi R. Sozzani S, Stine JT, et al. Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998;92:2668-71.
36. Loi KN, Leung JCK, Lai FM. Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T lymphocytes in vitro. Pathology 1991;23:224-8.
37. Butcher RDJ, Cushley W. Flow cytometric studies of IL-4 stimulated expression of CD25 antigen by quiescent human B lymphocyte subpopulations. Immunology 1991;74:511-18.
38. Roufosse F, Schandene L, Sibille C, et al. T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia. Blood 1999;94:994-1002.
39. + regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. J Respir Crit Care Med 2001;164:680-7.
40. Hoshino M, Nakamura Y, Shin Z, et al. Effects of Ketotifen on symptoms and on bronchial mucosa in patients with atopic asthma. Allergy 1997;52:814-20.
41. Bentley AM, Meng Q, Robinson DS, et al. Increases in activated T lymphocytes eosinophils, and cytokine mRNA expression for intedeukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
42. Igarashi Y, Goldrich MS, Kaliner MA, et al. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995;95:716-25.
43. Calderon MA, Lozewicz S, Prior A, et al. Lymphocyte infiltration and thickness of the nasal mucous membrane in perennia and seasonal allergic rhinitis. J Allergy Clin Immunol 1994;93:635-43.
44. Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol Today 1994;15:180-4.
45. De Meester I, Korom S, Van Damme J, et al. CD26, let it cut or cut it down. Immunol Today 1999;20:367-75.
46. Steinbrecher A, Reinhold D, Quigley L, et al. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-β1 secretion in vivo. J Immunol 2001;166:2041-8.
47. Van der Velden VHJ, Wierenga-Wolf AF, Adriaansen-Soeting PWC, et al. Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus. Clin Exp Allergy 1998;28:110-20.
48. Masuyama JI, Berman JS, Cruikshank WW, et al. Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol 1992;148:1367-74.
49. Struyf S, Proost P, Schols D, et al. CD26/dipeptidyl-peptidose IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 1999;162:4903-9.
50. Iwata S, Yamaguchi N, Munokota Y, et al. CD26/dipeptidyl peptidase IV differentially regulates the chemotoxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int Immunol 1999;11:417-26.
51. Wilhelm M, Ebner C, Baier K, et al. Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with TH1 subsets. J Allergy Clin Immunol 1997;100:348-55.
52. Del Prete G, De Codi M, D'Elios MM, et al. CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp med 1995;182:1655-61.
53. Hamann D, Hilkens CMU, Grogan JL, et al. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996;156: 1387-91.
54. Alzona M, Jack HM, Fisher RI, et al. CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J Immunol 1994;153:2861-7.
55. Dummer W, Rose C, Brocker EB. Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis. Arch Dermatol Res 1998;290-598-602.
56. Salmon M, Bacon PA, Symmons DP, et al. Transferrin receptor expression by stimulated cells in mixed lymphocyte culture. Immunology 1985;54:559-64.
57. Gallatin M, St John TP, Siegelman M, et al. Lymphocyte homing receptors. Cell 1986;44:673-80.
58. Munro JM, Briscoe DM, Tedder TF. Differential regulation of leucocyte L-selectin (CD62L) expression in normal lymphoid and inflamed extralymphoid tissues. J Clin Pathol 1996;49:721-7.
59. Wilder JA, Collie DDS, Bice DE, et al. Ovalbumin aerosols induce airway hyperreactivity in naive DO11.10 T cell receptor transgenic mice without pulmonary eosinophilia ar OVA-specific antibody. J Leukoc Biol 2001;69:538-47.
60. + T cells. Immunology 1996;87:186-90.